Glucose and cardiac risk factor control in individuals with type 2 diabetes: implications for patients and providers

Deborah Chyun1, Kimberly O Lacey1, Deborah M Katten2

  • 1The Yale University School of Nursing, New Haven, Connecticut (Dr Chyun, Ms Lacey, Dr Talley, Dr Melkus)

The Diabetes Educator
|November 15, 2006
PubMed

Insights

Many individuals with type 2 diabetes struggle to meet glucose and coronary heart disease (CHD) risk factor goals. Factors like age, therapy, and support systems influence goal achievement, indicating personalized strategies are needed.

Area of Science:

  • Cardiology
  • Endocrinology
  • Public Health

Background:

  • Type 2 diabetes management requires addressing both glycemic control and cardiovascular risk factors.
  • Suboptimal control of these factors contributes to significant morbidity and mortality.

Purpose of the Study:

  • To describe the achievement of glucose and coronary heart disease (CHD) risk factor goals in patients with type 2 diabetes.
  • To identify factors associated with successful goal attainment for these risk factors.

Main Methods:

  • A cross-sectional survey was conducted.
  • 110 subjects with type 2 diabetes were enrolled.
  • Participants were undergoing screening for asymptomatic myocardial ischemia.

Main Results:

  • A high percentage of participants did not meet glycemic targets (HbA1c > or =7%) or CHD risk reduction goals.
  • Individual (age, gender, anxiety), illness-related (lipid-lowering therapy, diabetes duration, medication use), and family-related (living situation, income, social support) factors were associated with various outcomes.
  • Personal beliefs and physical activity were consistently linked to lipid and weight management.

Conclusions:

  • Multiple factors influence the control of blood glucose and CHD risk factors in type 2 diabetes.
  • A standardized, one-size-fits-all approach to risk factor reduction may not be effective for all patients.
Abstract

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...